Liztox 200U

Product Details

Liztox 200U  

 

Basic Information & Composition

• Main Ingredient: Clostridium Botulinum Toxin Type A, 200U per vial

• Excipients: Albumin, Sodium Chloride

• Form: Injectable (white lyophilized powder, becomes a clear solution when dissolved in saline)

 

Indications

1. Glabellar LinesTemporary improvement of moderate to severe glabellar lines associated with activity of corrugator/procerus muscles 

2. Lateral Canthal Lines (Crow’s Feet)Temporary improvement of moderate to severe lateral canthal lines due to orbicularis oculi muscle activity 

3. Upper Limb SpasticityTreatment of upper limb spasticity related to stroke

    

Dosage & Administration

• Dilute with 0.9% preservative-free sterile saline to 200U/5.0mL (4U/0.1mL)

• Glabellar lines: inject 20U divided across 5 sites (corrugator/procerus)

• Lateral canthal lines: inject 24U in 6 sites (3 per side)

• Upper limb spasticity: doses tailored by muscle, not exceeding a total of 360U per session

• Effects last approximately 3–4 months

• Use only a single vial per patient

 

Key Precautions

• To be administered only by qualified medical professionals

• Do not exceed recommended dosage/processing frequency

• Systemic spread can cause: muscle weakness, dysphagia, respiratory distress, and has resulted in death in rare cases

• Hypersensitivity reactions (e.g., anaphylaxis, serum sickness, urticaria) have been reported

• Contraindicated for individuals with product hypersensitivity, neuromuscular junction disorders (e.g. myasthenia gravis, ALS, Eaton-Lambert syndrome), pregnant/nursing women, those with site infection/scar/skin disease

• Not recommended for pediatric patients (under 18), elderly over 66, or pregnant and breastfeeding women

• Use reconstituted solution within 24 hours; store at 2–8°C

 

Adverse Reactions

• Glabellar Lines: Most common adverse events include nasopharyngitis, cystitis, hypertension, and migraine; overall occurrence is similar to control group

• Lateral Canthal Lines: Most frequent events are nasopharyngitis and injection site bruising

• Upper Limb Spasticity (stroke patients): Most frequent events include COVID-19, dizziness, peripheral edema, and dyspepsia

• Most adverse reactions appear within one week and are transient, though sometimes persist for months

• Rare but serious cardiac, allergic, or local complications are possible

 

Drug Interactions

• Enhanced effects when administered along with aminoglycoside antibiotics, muscle relaxants, or anticholinergics

• Avoid combination with other botulinum toxin products or certain antibiotics (such as spectinomycin)

 

Liztox Injection 200Unit is a botulinum toxin type A product for the treatment of glabellar lines, crows feet, and post-stroke upper limb spasticity in adults, requiring strict adherence to medical guidelines and careful monitoring for safety.

 

 

 

Note

This product is intended for customers with professional knowledge in the relevant field.The information provided on this product page is for reference only and may contain errors or differ from the latest details.If you require precise specifications or further information, please contact us directly — we will respond promptly. We are continuously working to improve and minimize any inconvenience. Thank you for your kind understanding.